The European Central Bank must be “very agile and vigilant” to keep prices in check as the Iran war brings stagflation risks closer, Governing Council member Boris Vujcic said. Vujcic — who’ll become ECB vice president in June — said officials are likely to know soon whether fallout from the fighting will require higher interest rates. He warned, though, that recent developments point to increasin...
The European Central Bank must be “very agile and vigilant” to keep prices in check as the Iran war brings stagflation risks closer, Governing Council member Boris Vujcic said. Vujcic — who’ll become ECB vice president in June — said officials are likely to know soon whether fallout from the fighting will require higher interest rates. He warned, though, that recent developments point to increasing dangers of elevated consumer-price growth accompanied by weak economic expansion. “We do not see stagflation but the risk is moving into the direction of stagflation,” the Croatian central-bank chief said in an interview in Zagreb. “How far we’ll get in that direction is very difficult to predict.” Policymakers including Bundesbank President Joachim Nagel have indicated that the ECB will need to consider raising borrowing costs at next month’s rate meeting as soaring energy costs start feeding into inflation. Vujcic is keeping an open mind. “It’s a long time in today’s world until April,” he said. “There’ll be a lot of new data and news” and “in such situations, everything is live.” New ECB projections have consumer prices up 2.6% in the euro area this year in a baseline scenario — far more than previously thought. In an extreme outcome where disruptions to oil and natural gas supplies persist, inflation would hit 6.3%. While “the option value of waiting a bit is high” right now, Vujcic said “we’re already departing from the baseline scenario toward worst-case scenarios.” He sees two options if the ECB decides higher borrowing costs are needed: Begin early and make successive small hikes, or begin a bit later and raise in larger increments. “It’s better to start with a smaller move and then follow what’s going on,” Vujcic said. “For the time being, I would say it’s too early to say, but we will soon know whether we will have to act or not,” he said. Markets foresee as many as three quarter-point increases in the deposit rate this year from its current level of 2%. Economi...
The S&P Global Australia Manufacturing PMI decreased to 50.1 in March 2026 from 51.0 in February, indicating nearly stable conditions in the sector. This change was due to a slight drop in output and the first decline in new orders since July 2024, although export demand rose sharply. The S&P Global Flash Australia Services PMI Business Activity Index fell to 46.6 in March from 52.8 in February, m...
The S&P Global Australia Manufacturing PMI decreased to 50.1 in March 2026 from 51.0 in February, indicating nearly stable conditions in the sector. This change was due to a slight drop in output and the first decline in new orders since July 2024, although export demand rose sharply. The S&P Global Flash Australia Services PMI Business Activity Index fell to 46.6 in March from 52.8 in February, marking the first contraction in over two years. This decline was driven by a significant decrease in services activity and a drop in new business. Additionally, the S&P Global Flash Australia Composite PMI fell to 47.0 in March from 52.4 in February, signaling a contraction after eighteen months. The S&P/ASX 200 Index climbed 1.2% to 8,464 on Tuesday, snapping a three-session losing streak and rebounding from a ten-month low reached in the prior session. The Australian dollar weakened to around $0.69 on Tuesday, erasing gains from the previous session. Investors are now eyeing Wednesday’s inflation report for clues on the monetary policy outlook amid uncertainties stemming from ongoing Middle East tensions. More on Australia: EWA: Australian Financials May Struggle With A Flattening Yield Curve EWA: Potentially Range Bound, Given The Mix Of Tailwinds And Headwinds Australia's unemployment rate rises to 4.3% in February Odds of ECB rate hike rise amid Iran conflict-driven oil shock Seeking Alpha’s Quant Rating on iShares MSCI Australia ETF
(RTTNews) - The Progressive Corp. (PGR), an insurance holding company, on Monday, priced a $1.5 billion senior notes offering in an underwritten public offering. The offering includes $500 million of 4.60% senior notes due 2031, priced at 99.987% of par, and $1 billion of 5.15% senior notes due 2036, priced at 99.676% of par. The company is issuing the notes under an effective shelf registration s...
(RTTNews) - The Progressive Corp. (PGR), an insurance holding company, on Monday, priced a $1.5 billion senior notes offering in an underwritten public offering. The offering includes $500 million of 4.60% senior notes due 2031, priced at 99.987% of par, and $1 billion of 5.15% senior notes due 2036, priced at 99.676% of par. The company is issuing the notes under an effective shelf registration statement filed in May 2024. On Monday, the Progressive Corp. closed trading 0.44% lesser at $205.10 on the New York Stock Exchange. In the overnight, the stock further traded 0.51% lesser at $204.05. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Editor's note: Seeking Alpha is proud to welcome Jaden Mealy as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Sundry Photography/iStock Editorial via Getty Images Thesis 10x Genomics ( TXG ) is undervalued, as i...
Editor's note: Seeking Alpha is proud to welcome Jaden Mealy as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » Sundry Photography/iStock Editorial via Getty Images Thesis 10x Genomics ( TXG ) is undervalued, as investors continue to misinterpret a cyclical slowdown in instrument demand and current profitability issues as a structural weakness, while high-margin consumables ( over 80% of revenue ) continue to grow and signal strengthening underlying demand and an underappreciated "pole position" in single-cell biology markets. The market is currently focusing on short-term revenue contraction rather than the long-term shift toward higher-quality revenue streams. For these reasons, I rate the stock a BUY with ~18-20% upside as the company transitions to a recurring, cash-generative model. Company Overview & Operating Segments 10x Genomics manufactures technology focused on enabling high-resolution biological analysis within single-cell and spatial biology. Its tools, used widely across spaces such as academic research and biotechnology, can be split into 3 streams: Instruments: Single-sale instruments such as the Chromium X series provide platforms for companies to perform large-scale cell experiments and automate barcoding of individual DNA or RNA. Consumables: Specialized reagent kits , microfluidic chips, and other accessories designed for Chromium controllers and other instruments to be used in single-cell experiments, transforming cells into gene-sequencing-ready libraries. Software: Bioinformatic tools designed to process, analyze, and visualize data gathered by proprietary hardware, transforming raw data into usable and quantifiable results. The company operates in such a way as to first expand its instrument base, saturating the market with proprietary and sticky equipment, a...
Micron Technology (MU) stock has fallen by 12.4% in less than a month, from $461.73 on 18th Mar, 2026 to $404.35 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks that have a history of recovering from dips. As it turns out, MU stock passes basic quality checks. Historically, the median return for the 12-month period following sharp dips was 26% , with median peak re...
Micron Technology (MU) stock has fallen by 12.4% in less than a month, from $461.73 on 18th Mar, 2026 to $404.35 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks that have a history of recovering from dips. As it turns out, MU stock passes basic quality checks. Historically, the median return for the 12-month period following sharp dips was 26% , with median peak return reaching 49%. We define sharp dip as stock going down 20% or more, in less than 30 day period. Below, we get into details of historical dips and subsequent returns. Trefis: MU Stock Insights Historical Median Returns Post Dips Period Past Median Return 1M 0.9% 3M 2.7% 6M -2.0% 12M 26.5% Historical Dip-Wise Details MU had 20 events since 1/1/2010 where the dip threshold of -20% within 30 days was triggered 49% median peak return within 1 year of dip event median peak return within 1 year of dip event 339 days is the median time to peak return after a dip event days is the median time to peak return after a dip event -25% median max drawdown within 1 year of dip event 30 Day Dip MU Subsequent Performance Date MU SPY 1Y Peak Return Max Drop # Days to Peak Median 26% 49% -25% 339 4032025 -28% -12% 445% 522% -13% 349 12192024 -22% -1% 240% 207% -25% 365 7252024 -20% 1% 7% 19% -40% 334 12282022 -20% -4% 75% 79% 0% 363 9262022 -25% -14% 41% 52% 0% 242 6162022 -25% -15% 23% 36% -11% 344 4132022 -22% 2% -13% 4% -32% 50 3092020 -20% -17% 94% 106% -25% 357 5202019 -20% -2% 30% 73% -6% 275 12192018 -21% -8% 74% 74% -8% 365 9122018 -21% 3% 21% 21% -30% 364 4242018 -21% -5% -9% 33% -38% 35 12162015 -21% -1% 44% 47% -32% 358 6262015 -26% -1% -38% 2% -51% 21 10242012 -20% -2% 223% 258% 0% 348 4132012 -20% 0% 35% 45% -26% 362 10262011 -24% 5% 4% 62% -5% 125 6062011 -22% -4% -38% 0% -52% 0 7292010 -21% -1% -5% 52% -17% 203 5262010 -23% -12% 11% 36% -26% 267 Micron Technology Passes Basic Financial Quality Checks Revenue growth, profitability, cash flow, and balance sheet strength need t...
(RTTNews) - Gilead Sciences Inc. (GILD), on Monday, entered into a definitive agreement to acquire privately held Ouro Medicines. The deal includes $1.675 billion in upfront cash, with up to $500 million in additional milestone payments, and aims to strengthen the company's inflammation and autoimmune disease portfolio. The acquisition adds OM336 or gamgertamig, a clinical-stage BCMAxCD3 T cell en...
(RTTNews) - Gilead Sciences Inc. (GILD), on Monday, entered into a definitive agreement to acquire privately held Ouro Medicines. The deal includes $1.675 billion in upfront cash, with up to $500 million in additional milestone payments, and aims to strengthen the company's inflammation and autoimmune disease portfolio. The acquisition adds OM336 or gamgertamig, a clinical-stage BCMAxCD3 T cell engager designed for rapid and deep B cell depletion following a limited treatment course. The therapy is currently being evaluated in Phase 1/2 studies for autoimmune hemolytic anemia and immune thrombocytopenia, with plans to enter registrational studies in 2027. The company said OM336 has shown strong early efficacy and a differentiated safety profile after a single treatment cycle, with potential to enable durable immune reset and drug-free remission in certain patients. Additionally, the company is in advanced discussions with Galapagos NV (GLPG) for a potential research and development collaboration related to the acquired assets. Under the proposed collaboration, Galapagos would fund 50% of the upfront and milestone payments and take on most of Ouro's operations and employees. The development costs for OM336 would be borne by Galapagos through registrational studies, after which both companies would share costs equally. Gilead would retain global commercialization rights, excluding Greater China, and would pay Galapagos royalties ranging from 20% to 23% of net sales. On Monday, Gilead Sciences closed trading 0.09% higher at $137.34 on the Nasdaq. In the overnight trading, Gilead Sciences traded 0.09% lesser at $137.21. On Monday, Galapagos closed trading 0.34% lesser at $31.90 on the Nasdaq. In the after-hours, Galapagos traded 0.31% higher at $32. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
It’s been a rough winter. Profound personal loss, multiple global crises, surgery to remove a chunk of my thigh affected by melanoma and a perimenopausal body and brain that simply don’t bounce back like they used to have left me feeling not broken exactly, but fragile. Much as I did in the Covid lockdowns, I’ve been shifting my focus to nearby nature for a distraction and solace. A few days in be...
It’s been a rough winter. Profound personal loss, multiple global crises, surgery to remove a chunk of my thigh affected by melanoma and a perimenopausal body and brain that simply don’t bounce back like they used to have left me feeling not broken exactly, but fragile. Much as I did in the Covid lockdowns, I’ve been shifting my focus to nearby nature for a distraction and solace. A few days in bed, a few more propped in the kitchen window seat that I wisely insisted on when we rebuilt several years ago, then incrementally extending my hobble range to the front garden, I’ve experienced the arrival of spring in ways that are both limited and infinite, focusing closer and finding, once again, that seemingly small things expand exactly in proportion to the attention you give them. This week, I’ve been enjoying early butterflies, wild garlic in sudden abundance, the first migrant bird arrivals and the extraordinary reverse origami of bud burst. Full greening of the woodland canopy opposite our house is a few weeks off, but there’s a Frankenstein tree on our lawn that put out blossom a fortnight ago and is now coming into leaf. It’s supposed to be a greengage, but after a bit of an accident a couple of years back, the blackthorn rootstock to which it must have been grafted escaped, and now there are stems of both species growing from one base. Sloes and greengages from one tree is fine by me, and I can’t help but admire an organism so determined to be itself. Bud burst is one of the most powerful forces in nature. Once out, there is no way those leaves are ever going back. The hydraulic pressure (or turgor) inside the epidermal cells of an unfurling leaf can exceed the inflation pressure of a car tyre severalfold, exceeded only by that in growing tips of root and shoots that can burst through tarmac. I love these slightly absurd but arresting comparisons, the staple of children’s reference books: spider silk has the tensile strength of steel; an ant can carry 50 times it...
Oracle Corporation (NYSE: ORCL) Investor Alert: Deadline in Lawsuit on April 6, 2026 A Deadline is coming up on April 6, 2026 in the lawsuit for certain investors in Oracle Corporation (NYSE: ORCL). A deadline is coming up on April 6, 2026 in the lawsuit filed for certain investors of Oracle Corporation (NYSE: ORCL) over alleged securities laws violations by Oracle Corporation.Investors who purcha...
Oracle Corporation (NYSE: ORCL) Investor Alert: Deadline in Lawsuit on April 6, 2026 A Deadline is coming up on April 6, 2026 in the lawsuit for certain investors in Oracle Corporation (NYSE: ORCL). A deadline is coming up on April 6, 2026 in the lawsuit filed for certain investors of Oracle Corporation (NYSE: ORCL) over alleged securities laws violations by Oracle Corporation.Investors who purchased shares of Oracle Corporation (NYSE: ORCL) have certain options and there are strict and short deadlines running. Deadline: April 6, 2026. Oracle Corporation (NYSE: ORCL) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.Austin, TX based Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Oracle Corporation (NYSE: ORCL) reported that its Total Revenue rose from over $52.96 billion for the 12 months period that ended on May 31, 2024, to over $57.39 billion for the 12 months period that ended on May 31, 2025, and that its Net Income for those respective time periods rose from over $10.46 billion to over $12.44 billion.However, on September 24, 2025, S&P Global Ratings warned that OpenAI "could account for more than a third of total Oracle revenues by fiscal 2028 and even a greater share by fiscal 2030," creating risks given that "OpenAI's ability to meet contractual obligations will be contingent on AI tailwinds continuing and its models being a market leader to continue to raise external financing."The following day, on September 25, 2025, analysts at Rothschild & Co. Redburn initiated coverage of Oracle at "Sell," warning, among other things, that the Company's promises of massive new revenues from its increased AI infrastructure business were "unlikely to materialize" and set a $175 price target for Oracle-representing a 40% pullback in the Company's stock.After the market closed on December 10, 2025, Oracle announced its financial resul...
(RTTNews) - European stocks are seen opening lower on Tuesday amid skepticism the U.S. and Iran were close to end of war talks. Iran denied that it had engaged in negotiations with the United States. However, reports suggest the country is open to negotiations with tough conditions. The White House has played down reports regarding possible U.S.-Iran talks in Pakistan, calling the situation "fluid...
(RTTNews) - European stocks are seen opening lower on Tuesday amid skepticism the U.S. and Iran were close to end of war talks. Iran denied that it had engaged in negotiations with the United States. However, reports suggest the country is open to negotiations with tough conditions. The White House has played down reports regarding possible U.S.-Iran talks in Pakistan, calling the situation "fluid" and diplomatically sensitive. "These are sensitive diplomatic discussions, and the U.S. will not negotiate through the press," Press Secretary Karoline Leavitt said. "We are continuing our strikes against Iran and Lebanon without pause," Israeli Prime Minister Benjamin Netanyahu said, adding he spoke with U.S. President Donald Trump about safeguarding vital interests. Iran launched multiple waves of missiles at Israel this morning, Iranian state media reported. As the war drags on, Saudi Arabia and the United Arab Emirates are moving closer toward actively joining the fight against Iran, according to the Wall Street Journal. Asian markets were mostly higher in cautious trade as Trump's Iran war comments helped traders to price in a few basis points worth of Federal Reserve easing by the end of the year. Gold fell more than 1 percent, marking its tenth consecutive session of losses and deepening its grip in bear market territory, pressured by a stronger U.S. dollar and diminishing expectations of a Federal Reserve rate cut this year. Brent crude futures were up more than 4 percent to hover around $100 a barrel after plunging over 10 percent in the previous session. U.S. stocks rebounded overnight following President Trump's statement that the U.S. and Iran have had "very good and productive conversations regarding a complete and total resolution of hostilities in the Middle East" and therefore he has instructed the military to postpone any strikes against Iranian power plants and energy infrastructure for five days. However, Iran denied these talks had happened. "No negoti...
Farmers in South Africa are heading into the winter planting season with surging diesel prices and tightening supplies — triggered by the Middle East conflict — threatening production in sub-Saharan Africa’s largest commercial wheat-growing industry. For Rossouw Dippenaar, who farms near Riebeek-West about 80 kilometers (50 miles) northeast of Cape Town, time is running out. He needs as much as 40...
Farmers in South Africa are heading into the winter planting season with surging diesel prices and tightening supplies — triggered by the Middle East conflict — threatening production in sub-Saharan Africa’s largest commercial wheat-growing industry. For Rossouw Dippenaar, who farms near Riebeek-West about 80 kilometers (50 miles) northeast of Cape Town, time is running out. He needs as much as 40,000 liters (10,564 gallons) of diesel to plant his wheat, but has only secured about 6,000 liters because some retailers are limiting purchases in a bid to prevent a run on their stocks. “I don’t know what I will do if it doesn’t change in the next two weeks,” he said. “I’m living in hope that it will get better.” A five-day halt to US strikes on Iranian energy infrastructure announced by President Donald Trump on Monday eased global oil prices. But there’s little sign that trade will normalize any time soon. Iran continues to disrupt traffic through the Strait of Hormuz, restricting shipments from key oil and fertilizer producers such as Saudi Arabia, Qatar and Oman, and has dismissed Trump’s claims that ceasefire talks are underway. Unlike in many sub-Saharan African countries, most of South Africa’s crops are grown on commercial farms, with production heavily dependent on inputs such as fuel and fertilizer. Ethiopia produced about three times the 1.9 million tons of wheat that South Africa did last season, but it is primarily grown by small-scale farmers. Cost Shock “The combined effects of rising diesel and fertilizer prices present one of the most significant cost shocks to producers in recent years,” Richard Krige, chairman of Grain SA, which represents corn and wheat farmers, said in a statement. “The impact on farmer viability — and therefore food security — could be severe.” Since the US and Israel began bombing Iran on Feb. 28, global oil prices have surged by 40% or more and emerging-market currencies such as the South African rand have plunged. Fuel and fertili...